Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | CD20 |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 728917-18-8 |
ATC code | None |
UNII | BPD4DGQ314 |
Chemical data | |
Formula | C6458H9918N1706O2026S46 |
Mol. mass | 145.3 kDa |
(verify) |
(what is this?)
Veltuzumab is a monoclonal antibody which is being investigated for the treatment of non-Hodgkin's lymphoma.[1][2] As of December 2011[update], it is undergoing Phase I/II clinical trials.[3]
This drug was developed by Immunomedics, Inc.